Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 109

1.

The impact of congenital and childhood myotonic dystrophy on quality of life: a qualitative study of associated symptoms.

Johnson NE, Luebbe E, Eastwood E, Chin N, Moxley RT 3rd, Heatwole CR.

J Child Neurol. 2014 Jul;29(7):983-6. doi: 10.1177/0883073813484804. Epub 2013 Apr 22.

PMID:
23611887
2.

Parent-reported multi-national study of the impact of congenital and childhood onset myotonic dystrophy.

Johnson NE, Ekstrom AB, Campbell C, Hung M, Adams HR, Chen W, Luebbe E, Hilbert J, Moxley RT 3rd, Heatwole CR.

Dev Med Child Neurol. 2016 Jul;58(7):698-705. doi: 10.1111/dmcn.12948. Epub 2015 Oct 28.

3.

Picturing the Experience of Living With Myotonic Dystrophy (DM1): A Qualitative Exploration Using Photovoice.

LaDonna KA, Venance SL.

J Neurosci Nurs. 2015 Oct;47(5):285-95. doi: 10.1097/JNN.0000000000000160.

PMID:
26348433
4.

Patient-reported impact of symptoms in myotonic dystrophy type 1 (PRISM-1).

Heatwole C, Bode R, Johnson N, Quinn C, Martens W, McDermott MP, Rothrock N, Thornton C, Vickrey B, Victorson D, Moxley R 3rd.

Neurology. 2012 Jul 24;79(4):348-57. doi: 10.1212/WNL.0b013e318260cbe6. Epub 2012 Jul 11. Erratum in: Neurology. 2012 Sep 25;79(13):1411.

5.

Cognitive impairment and quality of life in patients with myotonic dystrophy type 1.

Fujino H, Shingaki H, Suwazono S, Ueda Y, Wada C, Nakayama T, Takahashi MP, Imura O, Matsumura T.

Muscle Nerve. 2018 May;57(5):742-748. doi: 10.1002/mus.26022. Epub 2017 Dec 8.

PMID:
29193182
6.

Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning.

Antonini G, Soscia F, Giubilei F, De Carolis A, Gragnani F, Morino S, Ruberto A, Tatarelli R.

J Rehabil Med. 2006 May;38(3):181-5.

7.

Emotional and behavioral profile and child psychiatric diagnosis in the childhood type of myotonic dystrophy.

Goossens E, Steyaert J, De Die-Smulders C, Willekens D, Fryns JP.

Genet Couns. 2000;11(4):317-27.

PMID:
11140408
8.

A Qualitative Approach to Health Related Quality-of-Life in Congenital Muscular Dystrophy.

Cornwall KM, Butterfield RJ, Hernandez A, Heatwole C, Johnson NE.

J Neuromuscul Dis. 2018;5(2):251-255. doi: 10.3233/JND-170252.

PMID:
29689733
9.

Quality of life in patients with myotonic dystrophy type 2.

Rakocevic Stojanovic V, Peric S, Paunic T, Pesovic J, Vujnic M, Peric M, Nikolic A, Lavrnic D, Savic Pavicevic D.

J Neurol Sci. 2016 Jun 15;365:158-61. doi: 10.1016/j.jns.2016.04.018. Epub 2016 Apr 16.

PMID:
27206898
10.

Understanding the experience of myotonic dystrophy. Mixed method study.

Geirdal AØ, Lund-Petersen I, Heiberg A.

J Genet Couns. 2015 Feb;24(1):169-78. doi: 10.1007/s10897-014-9752-1. Epub 2014 Aug 16.

11.

Patient-identified disease burden in facioscapulohumeral muscular dystrophy.

Johnson NE, Quinn C, Eastwood E, Tawil R, Heatwole CR.

Muscle Nerve. 2012 Dec;46(6):951-3. doi: 10.1002/mus.23529.

12.

Developmental Milestones and Quality of Life Assessment in a Congenital Myotonic Dystrophy Cohort.

Prasad M, Hicks R, MacKay M, Nguyen CT, Campbell C.

J Neuromuscul Dis. 2016 Aug 30;3(3):405-412.

PMID:
27854230
13.

Speech characteristics in the congenital and childhood-onset forms of myotonic dystrophy type 1.

Sjögreen L, Mårtensson Å, Ekström AB.

Int J Lang Commun Disord. 2018 May;53(3):576-583. doi: 10.1111/1460-6984.12370. Epub 2018 Jan 12.

PMID:
29327796
14.

A Review of Psychopathology Features, Personality, and Coping in Myotonic Dystrophy Type 1.

Minier L, Lignier B, Bouvet C, Gallais B, Camart N.

J Neuromuscul Dis. 2018;5(3):279-294. doi: 10.3233/JND-180310. Review.

15.

The Myotonic Dystrophy Health Index: Italian validation of a disease-specific outcome measure.

Sansone VA, Lizio A, Greco L, Gragnano G, Zanolini A, Gualandris M, Iatomasi M, Heatwole C.

Neuromuscul Disord. 2017 Nov;27(11):1047-1053. doi: 10.1016/j.nmd.2017.07.004. Epub 2017 Jul 10.

PMID:
28890289
16.

[Quality of life of patients with primary headaches, strokes and myotonic dystrophy].

Akhmadeeva LR, Magzhanov RV, Zakirova EN, Abdrashitov TM, Samigullina GD.

Zh Nevrol Psikhiatr Im S S Korsakova. 2008;108(11):72-5. Russian.

PMID:
19008806
17.

Orthopaedic manifestations of congenital myotonic dystrophy during childhood and adolescence.

Canavese F, Sussman MD.

J Pediatr Orthop. 2009 Mar;29(2):208-13. doi: 10.1097/BPO.0b013e3181982bf6.

PMID:
19352249
18.

Cardiac Abnormalities in Congenital and Childhood Myotonic Muscular Dystrophy Type 1.

Sharma A, Singh S, Mishra SK.

Neuropediatrics. 2017 Feb;48(1):42-44. doi: 10.1055/s-0036-1597546. Epub 2016 Dec 19.

PMID:
27992942
19.

Review of patient-reported outcome measures for use in myotonic dystrophy type 1 patients.

Symonds T, Randall JA, Campbell P.

Muscle Nerve. 2017 Jul;56(1):86-92. doi: 10.1002/mus.25469. Epub 2017 Mar 1. Review.

PMID:
27862031
20.

Participation restriction in childhood phenotype of myotonic dystrophy type 1: a systematic retrospective chart review.

Gagnon C, Kierkegaard M, Blackburn C, Chrestian N, Lavoie M, Bouchard MF, Mathieu J.

Dev Med Child Neurol. 2017 Mar;59(3):291-296. doi: 10.1111/dmcn.13282. Epub 2016 Sep 27.

Supplemental Content

Support Center